Best Life Sciences Companies in Alabama, United States
The 93 best Life Sciences companies in Alabama, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Serina Therapeutics.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Alabama
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Serina Therapeutics Developer of therapeutics to treat neurological diseases | $40M | 18 mo ago | Public | 9 | Michael Bentley Co-Founder | BugHerdQ4MediaElement.js+12 | — | 1 launch |
| 2 | Curiteva Developer of orthopedics surgery assistive devices | $32M | 31 mo ago | Series A | 87 87 → 56 (-36%) | — | WordPressMySQLPHP+22 | 39 patents 3D‑printed porous polymer implants and orthopedic fixation hardware for spine and bone surgery | — |
| 3 | Immunowake Developer of antibody-based therapeutics for the treatment of cancer | $20M | 49 mo ago | Seed | 2 | Xiaoyun Wu Co-Founder | — | 34 patents Engineered cytokine‑antibody fusion proteins for targeted immune modulation and therapy | — |
| 4 | Genisphere Offers a nanocarrier for targeted delivery of therapeutics. | $15M | 96 mo ago | Series B | 4 | — | — | 118 patents Molecular diagnostics for food allergy and gene‑therapy delivery vectors using peptides and nucleic‑acid carriers. | — |
| 5 | Resbiotic Provider of probiotic supplements to improve health | $10M | 9 mo ago | Series A | 11 | — | Cart FunctionalityShopifySentry+48 | — | 1 partnership · 1 award |
| 6 | Ash Access Technology Vascular access devices | $6M | 192 mo ago | Series B | — | Robert B. Truitt President & CEO | — | — | — |
| 7 | Gem Pharmaceuticals Specialty company developing anthracycline derivatives to eliminate cardiotoxicity side effect | $4M | 147 mo ago | Acqui-Hired | — | Gerald M Walsh CEO | — | — | — |
| 8 | Vital Metrix Non-invasive cardiac output monitoring | $4M | 92 mo ago | Seed | 5 | — | — | 12 patents Noninvasive cardiovascular monitoring and cardiac cycle analysis using optical/photonic sensors | — |
| 9 | Kailos Provider of consumer-based genetic testing services | $4M | 50 mo ago | Acquired | 10 10 → 18 (+80%) | Mike Walters Co-Founder and Board Member | DrupalPHPVideoJS+7 | — | — |
| 10 | XpertDox AI powered medical coding and clinical trials solutions provider | $4M | 41 mo ago | Seed | 34 | Bhupesh Panwar Co-Founder & COO | Node.jsTailwind CSSReact+19 | 2 patents AI-driven recommendation systems for selecting hospitals and physicians | 4 awards |
| 11 | New Century Pharmaceuticals Provider research and development for structural molecular biology and nano-material engineering | $3M | 160 mo ago | Deadpooled | — | Daniel Carter CEO | — | — | — |
| 12 | Vector Logics Oncolytic virus-based immunotherapies for ovarian cancers | $3M | 201 mo ago | Deadpooled | — | David Curiel Founder | — | — | — |
| 13 | Reliant Glycosciences Developer of diagnostic assays for chronic kidney disease | $2M | 24 mo ago | Funding Raised | 4 | Dana Rizk Co-Founder | Cart FunctionalityShopifySentry+11 | — | — |
| 14 | Bragg Peak Systems Innovating cancer therapy with carbon ion and proton systems | $2M | 178 mo ago | Seed | — | Paul Mulqueen CEO | — | — | — |
| 15 | Preventric Developer of a screening device for hypertension and vascular diseases | $2M | 60 mo ago | Deadpooled | 3 | Philip White Founder & Chairman | — | — | — |
| 16 | AlmataBio Developer of antibody therapeutics focused on inflammatory diseases, now acquired | $2M | 31 mo ago | Acquired | — | Patrick Crutcher CEO | — | — | — |
| 17 | HealthOme Provider of genetic test and support services for cancer | $2M | 19 mo ago | Seed | — | David Stertzer Co-Founder | Apple iCloud MailMicrosoft WordOpenSSL+20 | — | — |
| 18 | Vivo Biosciences Biotech company pioneering 3D bioassays for drug discovery and therapeutics | $2M | 142 mo ago | Acquired | — | Raj Singh CEO & President | — | — | — |
| 19 | GeneCapture Developer of a devices to detect and identify pathogens | $2M | 18 mo ago | Seed | 28 | Peggy L. Sammon CEO | — | 15 patents Nucleic acid capture reagents, integrated sample‑prep cartridges, and therapeutic target‑sensitivity assays | 1 launch |
| 20 | XO Armor Manufacturer of custom-fit, 3D-printed medical devices, splints, and orthotics | $2M | 10 mo ago | Seed | 10 | Michael Zabala Founder | Cart FunctionalityShopifyYouTube+18 | 12 patents Lightweight wear‑resistant coatings for aluminum alloys and modular armored vehicle body systems | 1 job opening · 1 partnership |
| 21 | Diatherix Laboratories Molecular diagnostics lab specializing in infectious disease testing with rapid turnaround | $2M | 173 mo ago | Acquired | 168 | Dennis Grimaud CEO & Chairman | — | — | 1 job opening |
| 22 | TriAltus Bioscience Simplified protein purification solutions, delivering ultra-pure, high-performance proteins and genomic… | $2M | 45 mo ago | Seed | 8 | Dmitry Vassylyev Co-Founder & CSO | — | — | — |
| 23 | Blondin Bioscience Developer of telomere-based liquid biopsy tests | $2M | 127 mo ago | Funding Raised | — | Katri Selander Founder & CSO | — | — | — |
| 24 | BioHorizons Developer of dental implant technologies and tissue regeneration products | $2M | 162 mo ago | Acquired | 331 331 → 500 (+51%) | — | Apple iCloud MailSalesforceVimeo+18 | — | 4 launchs |
| 25 | Nanoxort Provider of novel contrast agents for MRI and MRA procedures | $1M | 15 mo ago | Funding Raised | — | Allan David Co-Founder | — | 4 patents Nanoparticle size reduction techniques for biomedical drug delivery applications | — |
| 26 | Movi Medical Wheelchairs for patient transportation | $1M | 106 mo ago | Seed | 14 | Lloyd Cooper Founder | — | — | — |
| 27 | TransOMIC Omics reagent provider | $1M | 134 mo ago | Deadpooled | 15 | Gwen Fewell Co-Founder and Director | — | — | — |
| 28 | CerFlux Provider of personalized cancer treatment selection tests. | $1M | 34 mo ago | Seed | 8 | Karim Budhwani CEO | — | 14 patents Biomimetic sensor arrays for high‑throughput chemical/biological detection | — |
| 29 | Microarrays Provider of array-based technologies for biological research, detection, and diagnostics | $1M | 189 mo ago | Acquired | 11 | — | — | — | — |
| 30 | Volatile Analysis Provides analytical testing services for odor analysis | $1M | 120 mo ago | Seed | 8 | — | — | 26 patents Non‑invasive chemical and odor biomarker detection for exposure monitoring and disease prediction | — |
| 31 | Atherotech Medical technology news, insights, and updates from around the globe | $999K | 200 mo ago | Acquired | 471 | Jim McClintic CEO | — | 20 patents Clinical diagnostics for serum lipoprotein profiling and cell‑free nucleic acid assays. | — |
| 32 | Moremme Developer of hormone-free, natural vaginal health products | $870K | 15 mo ago | Funding Raised | — | Ore Adedoyin Co-Founder | — | — | — |
| 33 | Kalm Therapeutics Developer of skin patch for atopic dermatitis treatment | $700K | 22 mo ago | Seed | — | Anuj Singhal Founder & CEO | — | — | — |
| 34 | 3PH Alliance Provider of data analytics platform for healthcare practices | $400K | 42 mo ago | Funding Raised | 5 | Jose Osorio Founder and CMO | — | — | 1 partnership · 1 award |
| 35 | Nutech Medical Biologic and medical device company focusing on spinal and orthopedic surgical products | $325K | 184 mo ago | Acqui-Hired | 40 | — | — | — | — |
| 36 | VivoSphere Provider of 3D cell culture models for in vitro drug discovery and toxicity testing | $275K | 14 mo ago | Funding Raised | — | Elizabeth Lipke Co-Founder & CSO | — | — | 1 expansion · 1 award |
| 37 | CorAmi Developing a drug delivery device for treatment of cardiac fibrillation | $232K | 81 mo ago | Deadpooled | — | Rifat Pamukcu CEO | — | — | — |
| 38 | MilanaPharm Hydro-gel based proprietary drug delivery platform for treating chronic wounds | $195K | 89 mo ago | Seed | — | Jim Harwick CEO | — | — | — |
| 39 | Solle Naturals Adaptogen-fueled mind and body formulas for stress, energy, and wellness | $100K | 173 mo ago | Seed | 33 | Lon Hudman Co-Founder | Cart FunctionalityNode.jsCKEditor+21 | — | — |
Top 12 Life Sciences companies in Alabama
#1
Series A · Birmingham, Alabama · founded 2021 · 11 employees$10.1Mraised▾
Provider of probiotic supplements to improve health. It offers physician-formulated supplements including probiotics, prebiotics, and postbiotics aimed at restoring gut health and supporting lung, gut, and metabolic wellness.
- Sep 2025Series A$8M
- Feb 2025Seed$2.5M
- Jan 2024Seed$2.6M
- Mar 2023Grant (prize money)$1.3M
#2
Public · Huntsville, Alabama · founded 2007 · 9 employees$40.4Mraised▾
Developer of therapeutics to treat neurological diseases. Its proprietary POZ drug delivery platform is based on a water-soluble, low-viscosity polymer called poly(2-oxazoline) that is synthesized from readily available and safe starting materials. The pipeline has SER-214 for Parkinson’s Disease disorders and SER-226 for Postoperative pain management.
- Dec 2024Post IPO$10M
- Sep 2023Grant (prize money)$341K
- Jul 2022Post IPO$1M
- Jun 2020Post IPO$3.7M
#3
Seed · Auburn, Alabama · founded 2019 · 10 employees$1.9Mraised▾
Manufacturer of custom-fit, 3D-printed medical devices, splints, and orthotics. The company's on-site solution enables clinics to create personalized devices. It offers scanning software and 3D modeling technology to tailor durable medical equipment. The system optimizes stability, support, and mobility for improved patient outcomes.
- Jul 2025Seed$2.7M
- Apr 2023Seed$1.9M
#4
Seed · Huntsville, Alabama · founded 2010 · 28 employees$1.9Mraised▾
Developer of a device to detect and identify pathogens. The company's CAPTURE technology is based on a process that is a combination of RNA hybridization and optical sensing. It is used to detect infectious disease and antibiotic susceptibility testing.
- Nov 2024Seed$500K
- Sep 2021Seed$1.2M
- Sep 2020Seed$125K
- Jun 2019Seed$38.4K
#5
Funding Raised · Auburn, Alabama · founded 2018$1.3Mraised▾
Provider of novel contrast agents for MRI and MRA procedures. The company specializes in the development of novel MRI contrast agents, with a particular focus on iron-based, gadolinium-free agents to improve medical imaging accuracy and safety.
- Mar 2025Grant (prize money)$1M
- Mar 2021Grant (prize money)$256K
#6
Series A · Tanner, Alabama · founded 2018 · 87 employees$32.5Mraised▾
Curiteva is the developer of orthopedics surgery assistive devices. The platform has developed the aptitude is the anterior cervical system and sage is the cervical interbody fusion system that helps in spinal surgery.
- Nov 2023Series A$4M
- Dec 2020Series A$20.5M
- Nov 2019Series A$8M
#7
Funding Raised · Birmingham, Alabama · founded 2021$870.3Kraised▾
Developer of hormone-free, natural vaginal health products. These products are scientifically designed to maintain and revitalize vaginal health, focusing on pH balance, hydration, and repair. The company aims to boost women's confidence and comfort through its inclusive approach to intimate care solutions. A suite of plant-powered intimate therapeutics is planned for future release.
- Mar 2025Grant (prize money)$470.6K
- Aug 2024Grant (prize money)$399.8K
#8
Seed · Huntsville, Alabama · founded 2021$2Mraised▾
Provider of genetic test and support services for cancer. The company provides personalized cancer care with expert health navigation and genomic science. Also, it creates omics-based products for the critical illness and life insurance industry. It offers a test called "health ome one" which helps individuals understand their inherited risk of cancer.
- Nov 2024Seed$2M
- May 2024Seed—
#9
Funding Raised · Auburn, Alabama · founded 2022$275Kraised▾
Provider of 3D cell culture models for in vitro drug discovery and toxicity testing. The company creates human‑relevant 3D disease models using tissue‑engineering technologies, designed to mimic the structure and function of real tissues more closely than traditional 2D cell cultures.
- Mar 2025Grant (prize money)$275K
#10
Funding Raised · Birmingham, Alabama · founded 2015 · 4 employees$2.5Mraised▾
Developer of diagnostic assays for chronic kidney disease. The company offers proprietary biomarker-based tools IgA Nephropathy (IgAN) for the detection of nephropathy. The technology can detect the presence of Galactose-deficient IgA1 (Gd-IgA1) and an auto-antibody that recognizes Gd-IgA1.
- Jun 2024Grant (prize money)$977.8K
- Sep 2022Grant (prize money)—
- Jul 2020Grant (prize money)$1.5M
#11
Seed · Huntsville, Alabama · founded 2022$700Kraised▾
Developer of skin patch for atopic dermatitis treatment. The company is pioneering a groundbreaking, non-invasive treatment for eczema and psoriasis, utilizing a novel patch technology to provide relief from symptoms.
- Jul 2024Seed$700K
#12
Seed · Birmingham, Alabama · founded 2019 · 2 employees$20Mraised▾
Developer of antibody-based therapeutics for the treatment of cancer. The company is focused on the generation of multi-target antibodies against cancer. The company uses VEGF-Trap and CD3 Bi-specific platforms to design PD-L1 antibodies for the development of multi-target therapeutics.
- May 2022Seed$20M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
What Alabama researches in biotechnology
UAB and University of Alabama lead Alabama's biotech research, focusing on RNA interference, gene delivery, and glioma treatment, with a cautiously optimistic stance (mean 0.48) dominated by advancements.
- University of Alabama at Birmingham21
- University of Alabama6
- Alabama Agricultural and Mechanical University2
- Alabama Department of Forensic Sciences1
- Alabama State University1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.